<scp>MDM</scp>2 is a useful prognostic biomarker for resectable gastric cancer
Ye Yang(Peking University), Jianwei Zhou(Second Affiliated Hospital of Zhejiang University), Jianbing Zhang(Nanjing University), Yongfei Tan(Jiangsu University), Xuming Wu(Beijing University of Technology), Shuhan Miao(Jiangsu Cancer Hospital), Xiaowei Xia(Sun Yat-sen University), Xuan Li(Johns Hopkins University), Gang Li(Qiqihar Medical University), Song He(Nantong University), Fulin Qiang(Nantong University), Shouyu Wang(Nanjing Medical University), Yan Zhou(Nanchang University), Oluf Dimitri Røe(Norwegian University of Science and Technology), Jing‐Jing Yang(Jiangsu Cancer Hospital), Yansu Chen(Xuzhou Medical College)
Cited by 28
Related Papers
JAK2-binding long noncoding RNA promotes breast cancer brain metastasis
|Journal of Clinical Investigation|2017|231
Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma
|Journal of Clinical Oncology|2018|229
Shortlasting, Unilateral Neuralgiform Headache Attacks with Conjunctival Injection, Tearing, Sweating, and Rhinorrhea
|Cephalalgia|1989|226
Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic
|European Respiratory Review|2015|188
Prognostic and Predictive Role of JWA and XRCC1 Expressions in Gastric Cancer
|Clinical Cancer Research|2012|140